These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22145189)

  • 61. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 63. Establishment of drug codes for 26 substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2013 Jan; 78(3):664-6. PubMed ID: 23289157
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(25):6453-4. PubMed ID: 26859907
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Schedules of controlled substances; exempt anabolic steroid products. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Mar; 73(52):14178-9. PubMed ID: 18464343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pseudoephedrine laws in the US--are we doing enough?
    Murty S; Sansgiry SS
    Ann Pharmacother; 2006 Jun; 40(6):1213-5. PubMed ID: 16735651
    [No Abstract]   [Full Text] [Related]  

  • 68. Mexico's precursor chemical controls: emergence of less potent types of methamphetamine in the United States.
    Cunningham JK; Maxwell JC; Campollo O; Liu LM; Lattyak WJ; Callaghan RC
    Drug Alcohol Depend; 2013 Apr; 129(1-2):125-36. PubMed ID: 23127541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Infectious substances--DOT. Final rule.
    Fed Regist; 1995 Sep; 60(182):48780-7. PubMed ID: 10151186
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electronic Freedom of Information Act; implementation--USIA. Proposed rule.
    Fed Regist; 1998 Apr; 63(62):15800-2. PubMed ID: 10177759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medicaid program; time limitation on price recalculations and recordkeeping requirements under the drug rebate program. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Aug; 68(168):51912-7. PubMed ID: 12962118
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medicaid program; time limitation on recordkeeping requirements under the drug rebate program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Nov; 69(227):68815-8. PubMed ID: 15565749
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Mar; 69(53):12794-7. PubMed ID: 15029891
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Privacy Act of 1974; proposed implementation. Office of the Secretary, HHS. Final rule.
    Fed Regist; 2000 Jun; 65(115):37288-9. PubMed ID: 11010735
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug Enforcement Administration--Records and reports of registrants; central recordkeeping permits. Final rule.
    Fed Regist; 1980 Jul; 45(128 Pt 1):44266-7. PubMed ID: 10247077
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2011 Dec; 76(241):77895-99. PubMed ID: 22175093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Final rules relating to use of electronic communication and recordkeeping technologies by employee pension and welfare benefit plans. Notice of final rulemaking.
    Pension and Welfare Benefits Administration, Department of Labor
    Fed Regist; 2002 Apr; 67(68):17263-76. PubMed ID: 11944637
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medicare program; hospital outpatient prospective payment system and CY 2007 payment rates; CY 2007 update to the ambulatory surgical center covered procedures list; Medicare administrative contractors; and reporting hospital quality data for FY 2008 inpatient prospective payment system annual payment update program--HCAHPS survey, SCIP, and mortality. Final rule with comment period and final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Nov; 71(226):67959-68401. PubMed ID: 17133695
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Child abuse and neglect prevention and treatment program--HHS. Notice of proposed rulemaking.
    Fed Regist; 1985 Apr; 50(79):16105-9. PubMed ID: 10271279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.